Corcept Therapeutics (CORT) Current Deferred Revenue (2012 - 2015)
Corcept Therapeutics (CORT) reported Current Deferred Revenue of $158,000 for Q4 2015, up 378.8% from $33,000 a year earlier and up 100.0% from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) Current Deferred Revenue (2012 - 2015) Analysis & Trends
Dating back to Q2 2012, Corcept Therapeutics' Current Deferred Revenue record includes 15 quarters.
- Current Deferred Revenue has increased for three consecutive years, with a three-year compound annual growth rate of 114.5% (FY2012 to FY2015).
- By year, Current Deferred Revenue came in at $33,000 in FY2014 (+32.0%), $25,000 in FY2013 (+56.3%) and $16,000 in FY2012.
- The Q4 2015 figure ranks as the highest quarterly Current Deferred Revenue in data going back to Q2 2012.
- Year over year, Current Deferred Revenue gained in five of the last eight quarters, with growth averaging 61.3%.
- The high point for year-over-year Current Deferred Revenue in five years was Q4 2015 (growth of 378.8%); the low point was Q1 2014 (a decline of 61.8%).
- Per Business Quant data, the three quarters before Q4 2015 came in at $79,000 (Q3 2015), $37,000 (Q2 2015) and $55,000 (Q1 2015).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Corcept Therapeutics | 12.40 Bn | 10.96 Bn | 252.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 158,000.00 |
| Sep 30, 2015 | 79,000.00 |
| Jun 30, 2015 | 37,000.00 |
| Mar 31, 2015 | 55,000.00 |
| Dec 31, 2014 | 33,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Jun 30, 2014 | 44,000.00 |
| Mar 31, 2014 | 29,000.00 |
| Dec 31, 2013 | 25,000.00 |
| Sep 30, 2013 | 55,000.00 |
| Jun 30, 2013 | 37,000.00 |
| Mar 31, 2013 | 76,000.00 |
| Dec 31, 2012 | 16,000.00 |
| Sep 30, 2012 | 21,000.00 |
| Jun 30, 2012 | 26,000.00 |
API Access
Corcept Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();